FDA Approves VIZZ Eye Drops for Near Vision Improvement in Presbyopia Patients
By
geox
Hand-rolled, kettle-boiled, baked to perfection. Worth every minute at the bakery.
Summary
The FDA has approved VIZZ, the first aceclidine-based eye drop to improve near vision in adults with presbyopia, a condition affecting over 100 million adults in the US. Developed by LENZ, the once-daily drops provide relief for up to 10 hours and will be available within three months.
Key quotes
· 3 pulledThe FDA approval of VIZZ is a defining moment for LENZ and represents a transformative improvement in the available treatment options.
The first aceclidine-based eye drop to improve near vision in adults with presbyopia, which affects more than 100 million adults in the US alone, has been approved by the Food and Drug Administration.
The once-daily drops offer relief from blurry near vision for up to 10 hours.
You might also wanna read
Genomic test trial suggests hormone therapy alone may be sufficient for low-risk breast cancer patients
A groundbreaking genomic test trial suggests that breast cancer patients with low test scores could be treated with hormone therapy alone, a
apple.news·3h ago
Study finds bird masturbation is natural behavior, not caused by captivity stress
A study on masturbation among birds, particularly parrots, finds that the behavior is natural and more common in the wild than in captivity.
theguardian.com·3h ago
Experimental pill daraxonrasib extends survival in advanced pancreatic cancer patients, study finds
Researchers reported that daraxonrasib, a novel experimental pill, helped patients with advanced pancreatic cancer live longer by blocking a
npr.org·3h ago
Lab-grown sperm from stem cells could help infertile men, but may require gene editing
A US start-up called Paterna Biosciences claims it can take stem cells from men's testes and grow them into sperm cells in the lab, potentia
newscientist.com·4h ago
Spinach-derived photosynthetic treatment shows promise for dry eye disease
Scientists at the National University of Singapore have developed an experimental treatment for dry eye disease that uses photosynthetic mac
biotechniques.com·4h ago
Google's Debug program seeks EPA approval to release 64 million modified mosquitoes in California and Florida
Google's Debug program plans to release up to 64 million genetically modified "good" mosquitoes in California and Florida over two years to
bit.ly·5h ago